Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial
- 1 May 2000
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 19 (5), 410-417
- https://doi.org/10.1097/00006454-200005000-00005
Abstract
Influenza infection rates are higher in children than in other age groups. This study evaluated the efficacy, safety and tolerability of a 5-day course of twice daily inhaled zanamivir, 10 mg, compared with placebo in the treatment of symptomatic influenza A and B viral infections among children 5 to 12 years of age. This double blind, randomized, placebo-controlled, parallel group, multicenter study conducted in the Northern Hemisphere during the 1998 and 1999 influenza season enrolled 471 patients with influenza-like symptoms for ≤36 h. Patients were randomly assigned to zanamivir (n = 224) or placebo (n = 247). Symptoms were recorded on diary cards twice daily during treatment, for 9 days after treatment and for 14 additional days (if still reporting moderate/severe cough and/or taking relief medication). A total of 346 (73%) patients were influenza-positive by culture, serology or polymerase chain reaction (65% influenza A, 35% influenza B). Zanamivir reduced the median time to symptom alleviation by 1.25 days compared with placebo among patients with confirmed influenza infection (P Zanamivir was effective in shortening the duration and severity of influenza symptoms and was well-tolerated among children 5 to 12 years of age.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenzaPublished by American Medical Association (AMA) ,1996
- Recovery of drug-resistant influenza A virus during therapeutic use of rimantadineAntimicrobial Agents and Chemotherapy, 1991
- Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in FamiliesNew England Journal of Medicine, 1989
- Sample Size Determination for Some Common Nonparametric TestsJournal of the American Statistical Association, 1987
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981
- Infection with influenza A/Victoria virus in Houston families, 1976Epidemiology and Infection, 1981
- Consideration of the Risk of Influenza in Children and Indications for ProphylaxisClinical Infectious Diseases, 1980
- Viral Shedding Patterns of Children with Influenza B InfectionThe Journal of Infectious Diseases, 1979